Inserm Transfert SA, a Clause Samples

Inserm Transfert SA, a. Limited Company with a Board of Directors and a Supervisory Board, with a capital of 9,573,471 Euros, with registered office at ▇, ▇▇▇ ▇▇▇▇ - ▇▇▇▇▇ ▇▇▇▇▇, registered with the Trade and Companies Register of Paris under number Paris B 434 033 619, represented by the Chairman of its Board of Directors, ▇▇▇▇▇▇▇ ▇▇▇▇, acting as a delegate, of the National de la Santé et de la Recherche Médicale [National Institute of Health and Medical Research] (“INSERM”) a public scientific and technological institution, with registered office at ▇▇▇, ▇▇▇ ▇▇ ▇▇▇▇▇▇▇ - ▇▇▇▇▇ ▇▇▇▇▇ Cedex 13, France. Hereinafter referred to as “INSERM TRANSFERT”, UPMC, INSERM and CNRS are hereinafter jointly referred to as the “ESTABLISHMENTS”. UPMC, TINSERM and INSERM TRANSFERT, CNRS and the COMPANY are hereinafter jointly referred to as the “PARTIES”. It is specified that any notification of the PARTIES or to the PARTIES is validly made, with regard to INSERM, by or to INSERM TRANSFERT. UPMC, INSERM, CNRS and the COMPANY are hereinafter jointly referred to as the “CO-OWNERS”. Given the application convention of the quadrennial contract between UPMC and CNRS in force at the time of said invention; Given the partnership agreement between UPMC and INSERM, concluded on 29 March 2009 for which a new agreement was signed on 22 December 2015, in force at the time of said invention; Given the beneficiary agreement no. ANR-10-SATT-04-01 signed between Agence Nationale de la Recherche (National Research Agency), University Pierre et ▇▇▇▇▇ ▇▇▇▇▇, Université de technologie de Compiègne, Université Panthéon Assas, Institut Européen d’Administration des Affaires (European Institute of Business Administration) and Centre National de la Recherche Scientifique (National Centre for Scientific Research), in the presence of the Caisse des Dépôts et Consignation (Deposits and Consignments Fund) on 17 January 2012; Given the articles of association of SATT LUTECH signed on 31 January 2012; Given the framework agreement concluded between UPMC and SATT LUTECH and any addendum or supplementary document relating thereto. INSERM TRANSFERT, a private-law subsidiary of INSERM, and INSERM have concluded a public service delegation contract under which INSERM has delegated to INSERM TRANSFERT the management of its technology recovery and transfer tasks, such as they result from Decree No. 83-975 on the operation and organisation of TINSERM. Pursuant to this public service delegation agreement, INSERM TRANSFERT received the...
View SourceView Similar (3)

Related to Inserm Transfert SA, a

  • Automatic Renewal Clauses Incorporated in Awarded Vendor Agreements with TIPS Members Resulting from the Solicitation and with the Vendor Named in this Agreement.

  • Transfer of Interest Amount The transfer of the Interest Amount will be made on the second Local Business Day following the end of each calendar month to the extent that Party B has earned and received such amount of interest and that a Delivery Amount would not be created or increased by that transfer, and on any other Local Business Day on which Equivalent Credit Support is transferred to the Transferor pursuant to Paragraph 2(b), provided that Party B shall only be obliged to transfer any Interest Amount to Party A to the extent that it has received such amount.

  • Transfer of Beneficial Interests to Another Restricted Global Note A beneficial interest in any Restricted Global Note may be transferred to a Person who takes delivery thereof in the form of a beneficial interest in another Restricted Global Note if the transfer complies with the requirements of Section 2.06(b)(ii) hereof and the Registrar receives the following: (A) if the transferee will take delivery in the form of a beneficial interest in a 144A Global Note, then the transferor must deliver a certificate in the form of Exhibit B hereto, including the certifications in item (1) thereof; or (B) if the transferee will take delivery in the form of a beneficial interest in a Regulation S Global Note, then the transferor must deliver a certificate in the form of Exhibit B hereto, including the certifications in item (2) thereof.

  • Check if Transfer is Pursuant to Regulation S (i) The Transfer is being effected pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any state of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will no longer be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes, on Restricted Definitive Notes and in the Indenture.

  • Transfer of Beneficial Interests to Another Restricted Global Security A beneficial interest in a Transfer Restricted Global Security may be transferred to a Person who takes delivery thereof in the form of a beneficial interest in another Transfer Restricted Global Security if the transfer complies with the requirements of Section 2.2(b)(ii) above and the Registrar receives the following: (A) if the transferee will take delivery in the form of a beneficial interest in a Rule 144A Global Security, then the transferor must deliver a certificate in the form attached to the applicable Security; and (B) if the transferee will take delivery in the form of a beneficial interest in a Regulation S Global Security, then the transferor must deliver a certificate in the form attached to the applicable Security.